SEC 13F Intelligence

PROTEOSTASIS THERAPEUTICS IN

CUSIP 74373B109

Proteostasis Therapeutics In has 1 institutional holders in Filings Flow’s 13F database, together reporting 150 shares worth $171 as of Q1 2023.

Institutional Holders
1
Q1 2023
Reported Value
$171
Ticker
unmapped
private placement or foreign
Quarters Tracked
8

Ownership Trend

Institutional holders
Q1 ’19: 59Q1 ’19Q2 ’19: 40Q2 ’19Q3 ’19: 33Q3 ’19Q4 ’19: 37Q4 ’19Q1 ’20: 34Q1 ’20Q2 ’20: 38Q2 ’20Q3 ’20: 31Q3 ’20Q1 ’23: 1Q1 ’23filingsflow.com
Total reported value
Q1 ’19: $22MQ1 ’19Q2 ’19: $16MQ2 ’19Q3 ’19: $11MQ3 ’19Q4 ’19: $20MQ4 ’19Q1 ’20: $9MQ1 ’20Q2 ’20: $7MQ2 ’20Q3 ’20: $9MQ3 ’20Q1 ’23: $171Q1 ’23filingsflow.com

Holders

··
Export to Excel
Manager% of PortfolioValueSharesQuarter
American Portfolios Advisors$1.2B AUM0.00%$171150Q1 2023

Holdings are reported up to 45 days after quarter end. Share counts are as filed and not adjusted for stock splits.